[go: up one dir, main page]

TR200101507T2 - Geniş antibakteriyel spektrumu olan imidazo[4,5-b] piridinyummetil-içerikli sefem bileşimleri - Google Patents

Geniş antibakteriyel spektrumu olan imidazo[4,5-b] piridinyummetil-içerikli sefem bileşimleri

Info

Publication number
TR200101507T2
TR200101507T2 TR2001/01507T TR200101507T TR200101507T2 TR 200101507 T2 TR200101507 T2 TR 200101507T2 TR 2001/01507 T TR2001/01507 T TR 2001/01507T TR 200101507 T TR200101507 T TR 200101507T TR 200101507 T2 TR200101507 T2 TR 200101507T2
Authority
TR
Turkey
Prior art keywords
hydrogen
pyridiniummethyl
cefem
imidazo
compositions
Prior art date
Application number
TR2001/01507T
Other languages
English (en)
Inventor
Nishitani Yasuhiro
Itani Hikaru
Irie Tadashi
Original Assignee
Shionogi & Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co., Ltd. filed Critical Shionogi & Co., Ltd.
Publication of TR200101507T2 publication Critical patent/TR200101507T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

X'in N veya CY ve Y'nin H veya halojen; R1'in amino veya korumali amino; R'nin hidrojen, tercihe göre ikameli alt alkil, vs; R3'ün hidrojen vs; R4'ün hidrojen, tercihe göre ikameli alt alkil veya tercihe göre ikameli N-içeren heterosiklik grup vs; R5'in hidrojen vs; ve kivrimli çizginin bir sin-veya antiizomerizmi, veya bir karisimi oldugu bir formül (1); sefem bilesimi, MRSA dahil, çesitli patojenik bakterilere karsi genis antibakteriyel spektrum göstermektedir.
TR2001/01507T 1998-11-27 1999-11-25 Geniş antibakteriyel spektrumu olan imidazo[4,5-b] piridinyummetil-içerikli sefem bileşimleri TR200101507T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33670798 1998-11-27

Publications (1)

Publication Number Publication Date
TR200101507T2 true TR200101507T2 (tr) 2001-09-21

Family

ID=18301969

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01507T TR200101507T2 (tr) 1998-11-27 1999-11-25 Geniş antibakteriyel spektrumu olan imidazo[4,5-b] piridinyummetil-içerikli sefem bileşimleri

Country Status (23)

Country Link
US (2) US6518263B1 (tr)
EP (1) EP1134222B1 (tr)
JP (1) JP3636663B2 (tr)
KR (1) KR100692169B1 (tr)
CN (1) CN100436456C (tr)
AT (1) ATE293114T1 (tr)
AU (1) AU758662B2 (tr)
BR (1) BR9915743A (tr)
CA (1) CA2350905C (tr)
CZ (1) CZ20011719A3 (tr)
DE (1) DE69924751T2 (tr)
ES (1) ES2241374T3 (tr)
HU (1) HUP0200450A3 (tr)
ID (1) ID28740A (tr)
IL (1) IL143314A0 (tr)
NO (1) NO20012554L (tr)
NZ (1) NZ511619A (tr)
PL (1) PL347897A1 (tr)
RU (1) RU2223964C2 (tr)
TR (1) TR200101507T2 (tr)
TW (1) TW526202B (tr)
WO (1) WO2000032606A1 (tr)
ZA (1) ZA200103850B (tr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
ATE285821T1 (de) * 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
JP2003012647A (ja) * 2000-10-04 2003-01-15 Shionogi & Co Ltd ２，３−ジアミノピリジンの製造方法
US7049310B2 (en) * 2001-04-06 2006-05-23 Affinium Pharmaceuticals, Inc. Fab I inhibitors
ATE303390T1 (de) * 2001-04-23 2005-09-15 Shionogi & Co Sulfat von cephemverbindung
WO2003068745A1 (en) * 2002-02-14 2003-08-21 Shionogi & Co., Ltd. Process for production of 2,3-diaminopyridine derivatives
EP1485348B1 (en) * 2002-03-13 2008-06-11 Janssen Pharmaceutica N.V. Carbonylamino-derivatives as novel inhibitors of histone deacetylase
WO2004000323A1 (ja) * 2002-06-21 2003-12-31 Shionogi & Co., Ltd. セフェム化合物の注射用医薬組成物
JPWO2004026882A1 (ja) * 2002-09-20 2006-01-19 塩野義製薬株式会社 セフェム剤の製法
AU2003275682A1 (en) * 2002-10-29 2004-05-25 Shionogi And Co., Ltd. Crystal of inorganic acid salt of cephem compound
BRPI0315188B8 (pt) 2002-10-30 2021-05-25 Astellas Pharma Inc composto e composição farmacêutica
AU2002952355A0 (en) * 2002-10-30 2002-11-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JP4859460B2 (ja) 2002-12-06 2012-01-25 アフィニウム ファーマシューティカルズ， インク． ヘテロ環化合物、その製造方法および治療におけるその使用
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
CN1852715A (zh) 2003-09-18 2006-10-25 安斯泰来制药有限公司 头孢类化合物
JP4535366B2 (ja) * 2003-12-03 2010-09-01 塩野義製薬株式会社 セフェム剤の製造方法
TW200530255A (en) * 2004-03-05 2005-09-16 Shionogi & Co 3-pyridiniummethylcefem compound
CA2568914C (en) 2004-06-04 2013-09-24 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
JP2006206529A (ja) * 2005-01-31 2006-08-10 Shionogi & Co Ltd Ｎ−（４−ピリジル）エチレンジアミン誘導体
EP1973902A2 (en) * 2005-12-05 2008-10-01 Affinium Pharmaceuticals, Inc. 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
US8318720B2 (en) 2006-07-20 2012-11-27 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as Fab I inhibitors
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
US8198434B2 (en) * 2008-05-07 2012-06-12 Idexx Laboratories, Inc. Process for preparing cefsulodin sodium
CN102443017B (zh) * 2010-10-13 2014-10-29 石药集团中奇制药技术（石家庄）有限公司 一种盐酸头孢唑兰的制备方法
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
WO2013190384A1 (en) 2012-06-19 2013-12-27 Affinium Pharmaceuticals, Inc. Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
JP6321662B2 (ja) 2012-10-12 2018-05-09 ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. Ｇｓｋ３阻害剤およびその使用の方法
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
EP2893929B1 (en) 2013-03-15 2025-04-16 Merck Sharp & Dohme LLC Ceftolozane antibiotic compositions
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
ES2729026T3 (es) * 2015-06-29 2019-10-29 Sandoz Ag Procedimiento para la preparación de derivados de carbamoilamino pirazol
BR112018009725A8 (pt) * 2015-12-10 2019-02-26 Naeja Rgm Pharmaceuticals Ulc compostos de cefém, sua produção e uso
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
US11203601B2 (en) 2017-04-05 2021-12-21 The Broad Institute, Inc. Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof
CN116327781A (zh) 2019-02-14 2023-06-27 德彪药业国际股份公司 阿法比星制剂及其制备方法
MA56184A (fr) 2019-06-14 2022-04-20 Debiopharm Int Sa Afabicine pour utilisation dans le traitement d'infections bactériennes impliquant un biofilm

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3585199A (en) * 1967-05-25 1971-06-15 Merck & Co Inc (4-(3-(polyazaheterocyclic)alkanoyl)phenoxy)alkanoic acids
US4002623A (en) 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
GR75644B (tr) 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
DE3279470D1 (en) 1981-04-03 1989-04-06 Fujisawa Pharmaceutical Co New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
PL238158A1 (en) 1981-09-08 1984-11-19 Lilly Co Eli Method of obtaining new cephalosporin derivatives
US4406899A (en) 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
ZA838864B (en) * 1982-12-17 1984-11-28 Ici Pharma Process for the manufacture of cephalosporin derivatives
DE3248281A1 (de) 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
US4525473A (en) 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3409431A1 (de) 1983-10-08 1985-04-18 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3336757A1 (de) 1983-10-08 1985-04-25 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
GB2148289B (en) * 1983-10-17 1987-09-23 Lilly Co Eli 3-bicyclicpyridinium-methyl cephalosporins
US4692443A (en) * 1983-10-17 1987-09-08 Eli Lilly And Company 3-bicyclicpyridinium-methyl cephalosporins
JPS60120889A (ja) 1983-11-30 1985-06-28 Meiji Seika Kaisha Ltd 新規セファロスポリン化合物及びその製造法
US4547573A (en) 1983-12-02 1985-10-15 Ici Pharma Process for preparing cephalosporin derivatives
GB8401093D0 (en) 1984-01-16 1984-02-15 Fujisawa Pharmaceutical Co Cephem compounds
WO1986005184A1 (fr) * 1985-03-01 1986-09-12 Takeda Chemical Industries, Ltd. Composes antibacteriens
NO165842C (no) 1984-04-23 1991-04-17 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
IL77458A (en) 1985-01-14 1990-07-26 Eisai Co Ltd Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor
NO166283C (no) 1985-03-01 1991-06-26 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(5-amino-1,2,4-tiadiazol-3-yl)-2(z)-substituertoksyiminoacetamido)-3-(heterocyclylmetyl)-3-cefem-4-karboksylsyrederivater.
ATE89826T1 (de) 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
US4804658A (en) 1986-09-15 1989-02-14 G. D. Searle & Co. Imidazopyridine derivatives and pharmaceutical compositions
GB8712747D0 (en) * 1987-05-30 1987-07-01 Pfizer Ltd Therapeutic agents
JPH0248587A (ja) * 1988-08-10 1990-02-19 Yamanouchi Pharmaceut Co Ltd 複素環置換ビスフォスフォン酸誘導体及びその医薬
JPH02286679A (ja) * 1989-04-28 1990-11-26 Grelan Pharmaceut Co Ltd イミダゾピリジン誘導体
US5332744A (en) 1989-05-30 1994-07-26 Merck & Co., Inc. Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5298518A (en) 1989-09-29 1994-03-29 Eisai Co., Ltd. Biphenylmethane derivative and pharmacological use
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
EP0434038A1 (en) * 1989-12-22 1991-06-26 Takeda Chemical Industries, Ltd. Fused imidazole derivatives, their production and use
FR2672052B1 (fr) 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
DE4005970A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte maleinimide, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
EP0461040A1 (fr) * 1990-06-08 1991-12-11 Roussel Uclaf Dérivés de l'imidazole, leur procédé de préparation, les intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant
AU8506791A (en) 1990-10-01 1992-04-28 Janssen Pharmaceutica N.V. Novel 4-piperidinylcarbonyl derivatives
US5281589A (en) 1991-06-15 1994-01-25 Cheil Foods & Chemicals, Inc. 3-fused pyridiniummethyl cephalosporins
JPH05201991A (ja) * 1991-07-10 1993-08-10 Dainippon Pharmaceut Co Ltd アミノ酸誘導体
JPH05222058A (ja) 1992-02-17 1993-08-31 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
JPH0641149A (ja) * 1992-05-28 1994-02-15 Toyama Chem Co Ltd 新規なセファロスポリン誘導体およびその塩
JP3269658B2 (ja) * 1992-06-02 2002-03-25 エーザイ株式会社 フェノール誘導体
GB9216287D0 (en) 1992-07-31 1992-09-16 Fujisawa Pharmaceutical Co New cephem compounds
JPH07101958A (ja) 1992-10-16 1995-04-18 Takeda Chem Ind Ltd セフェム化合物、その製造法および抗菌組成物
US5334598A (en) 1993-03-19 1994-08-02 Merck & Co., Inc. Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
DE4309969A1 (de) 1993-03-26 1994-09-29 Bayer Ag Substituierte heteroanellierte Imidazole
JPH07101960A (ja) 1993-10-05 1995-04-18 Takeda Chem Ind Ltd セフェム化合物、その製造法および抗菌組成物
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
DE4416433A1 (de) * 1994-05-10 1995-11-16 Hoechst Ag Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US5635514A (en) 1994-10-25 1997-06-03 G. D. Searle & Company Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09165371A (ja) 1995-10-09 1997-06-24 Sankyo Co Ltd 複素環化合物を含有する医薬
JPH09110877A (ja) * 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤
FR2742052B1 (fr) * 1995-12-12 1998-04-10 Esteve Labor Dr Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports
AUPN955596A0 (en) 1996-04-30 1996-05-23 Fujisawa Pharmaceutical Co., Ltd. New compound
ZA977103B (en) * 1996-08-09 1999-02-08 Eisai Co Ltd Benzopiperidine derivatives
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity

Also Published As

Publication number Publication date
NZ511619A (en) 2002-11-26
US6800621B2 (en) 2004-10-05
EP1134222A1 (en) 2001-09-19
EP1134222B1 (en) 2005-04-13
NO20012554D0 (no) 2001-05-23
HUP0200450A3 (en) 2004-04-28
NO20012554L (no) 2001-07-27
BR9915743A (pt) 2001-08-21
AU758662B2 (en) 2003-03-27
ATE293114T1 (de) 2005-04-15
TW526202B (en) 2003-04-01
ZA200103850B (en) 2002-05-13
CA2350905A1 (en) 2000-06-08
DE69924751T2 (de) 2006-03-09
CA2350905C (en) 2007-10-23
IL143314A0 (en) 2002-04-21
RU2223964C2 (ru) 2004-02-20
WO2000032606A1 (en) 2000-06-08
KR100692169B1 (ko) 2007-03-12
DE69924751D1 (de) 2005-05-19
HUP0200450A2 (hu) 2002-07-29
ES2241374T3 (es) 2005-10-16
KR20010086058A (ko) 2001-09-07
US6518263B1 (en) 2003-02-11
ID28740A (id) 2001-06-28
JP3636663B2 (ja) 2005-04-06
PL347897A1 (en) 2002-04-22
CN100436456C (zh) 2008-11-26
US20030149014A1 (en) 2003-08-07
AU1409000A (en) 2000-06-19
EP1134222A4 (en) 2003-01-29
CN1333776A (zh) 2002-01-30
CZ20011719A3 (cs) 2001-12-12

Similar Documents

Publication Publication Date Title
TR200101507T2 (tr) Geniş antibakteriyel spektrumu olan imidazo[4,5-b] piridinyummetil-içerikli sefem bileşimleri
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
DE69918422D1 (de) Phthalazinone pde iii/iv hemmer
YU72002A (sh) Benzoilpirazoli i njihova primena u ulozi herbicida
BR0213140A (pt) Fungicidas de pirazol-pirimidina
YU78303A (sh) Postupak za dobijanje 1,3-supstituisanih indena i azapolicikličnih jedinjenja sa pripojenim arilom
TR199900856T2 (tr) Bronsla ilgili terapi maddeleri olarak benzonaftiridinler
SE9702773D0 (sv) Novel compounds
PL341239A1 (en) Dihydrobenzofuranes
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
TR200001950T2 (tr) İkameli 2-benzilamino-2-fenil-asetamid bileşikler.
MXPA05010651A (es) Compuestos de pirazol.
MXPA04001773A (es) Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos.
SI1377574T1 (tr)
DE60125053D1 (de) Cephem verbindungen und diese enthaltende esbl nachweisreagenzien
SE9802574D0 (sv) Novel compounds
MXPA02007973A (es) Compuestos de aminoacidos y su uso como inhibidores de nep, ace y ece.
ATE223462T1 (de) Naphthalenehydrazamimide und perylenhydrazamimide
GB9923710D0 (en) Chemical compounds
TR200103332T2 (tr) 1-Triflorometil-4-hidroksi-7-piperidinil-aminometilkroman türevleri.
DE60106730D1 (de) Aromatische aminhärter und ihre verwendung
TR200103042T2 (tr) N”rotrofin g‡lendiricileri
WO1999059996A8 (en) Antitumour 1,5-diazaanthraquinones
BR0317151A (pt) Misturas de agentes de branqueamento fluorescentes